News | January 03, 2024
Strides Pharma Science to invest in AMP-6, AMP-8
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
AMP-6 & AMP-8 are special purpose entities formed for purpose of setting up captive solar power projects in Karnataka
Trinity has availed credit facility from Investec for Business for their working capital requirements of Rs. 31.5 crore
The company has posted net loss of Rs. 460.21 crores for the Financial Year ended March 31, 2022.
Strides Pharma Science has reported consolidated financial results for the period ended September 30, 2021
Strides Pharma Science reported total income of Rs.3367.29 crores during FY 2020-21
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Prozac Tablets of Eli Lilly
Christoph Funke's extensive career includes leadership roles at organizations such as Fresenius Kabi and Strides Pharma Science
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
The Pregabalin capsules has a market size of ~US$248 mn per IQVIA
Arco Lab now holds a 50% stake in Neviton
Subscribe To Our Newsletter & Stay Updated
_256_275.jpg)